US ETFDetailed Quotes

COYA Coya Therapeutics

Watchlist
  • 6.850
  • -0.190-2.70%
Close Nov 4 16:00 ET
113.71MMarket Cap-9256P/E (TTM)

About Coya Therapeutics Company

Coya Therapeutics, Inc. is a clinical-stage biotechnology company which engages in developing proprietary medicinal products to modulate the function of regulatory T cells. The company was founded by Howard Berman in 2020 and is headquartered in Houston, TX.

Company Profile

SymbolCOYA
Company NameCoya Therapeutics
Listing DateDec 29, 2022
Issue Price5.00
Founded2020
CEODr. Arun Swaminathan, PhD
MarketNASDAQ
Employees8
Fiscal Year Ends12-31
Address5850 San Felipe Street,Suite 500
CityHouston
ProvinceTexas
CountryUnited States of America
Zip Code77057
Phone1-800-587-8170
Websitehttp://www.coyatherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Arun Swaminathan, PhD
  • Chief Executive Officer
  • --
  • Dr. Fred Grossman
  • President and Chief Medical Officer
  • 592.48K
  • David S. Snyder, M.B.A.
  • Principal Accounting Officer, Chief Financial Officer and Chief Operating Officer
  • 947.89K
  • Dr. Howard Berman, PhD
  • Executive Chairman of the Board
  • 1.32M
  • Dr. Ann Lee, PhD
  • Independent Director
  • 52.50K
  • Dr. Anabella Villalobos, PhD
  • Independent Director
  • 53.75K
  • Wilbur L. Ross, Jr
  • Independent Director
  • --
  • Dieter Weinand
  • Independent Director
  • 44.16K
  • Dr. Dov A. Goldstein, M.B.A.,M.D.
  • Independent Director
  • 63.75K
  • Dr. Hideki Garren, M.D.,PhD
  • Independent Director
  • 55.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data